|
|
||||||||
Modified human immunodeficiency virus comprising, in its genome, chimeric recombinant gene constructvirus thymidine-kinase gene transfer and aciclovir or ganciclovir prodrug activation using an HIV virus vector with improved safety; for AIDS gene therapy.
Clinical-Technologies WO 97-09059
Low molecular weight cell, bone marrow, and immune stimulantsare peptide-like cpds. Used to enhance vaccination, synthesis and function of blood cell components and anti-neoplastic effects of various agents.
Dovetail Tech., Inc. WO 97-14306
Transduction system based on rep-negative adeno-associated virus vectorwith tissue-specific gene expression and separate Rep protein function; for use in gene therapy in vivo or ex vivo.
MediGene WO 97-09488
Mutant human erythropoietin proteinsuseful for promoting or inhibiting red blood cell progenitor growth and differentiation.
New England Deaconess Hospital US 5614184
Retroviral vectors having altered env and/or gag-pol region protein-retro virus vector production in packaging cell culture; for application in, e.g., leukemia and AIDS gene therapy.
Oxford-Biomedical WO 97-09521
Ten new chemokines able to mobilize stem cells used where increased levels of hematopoietic cells are required; e.g., to increase resistance to infection.
SmithKline Beecham Corporation WO 97-15594
Use of specific chemokine(s) for stem cell mobilizationuseful for treating myelosuppression or any condition involving immuno-suppression or low levels of haematopoietic cells.
SmithKline Beecham Corp. WO 97-15595
Early identification of auto-immune diseasefrom presence of autoantibodies against cytokine(s), especially for diseases that result in thrombopenia, thrombosis, etc.
Soc Diagnostica-Stago WO 97-11373
Isolated cluster-forming stem cells from early fetus hematopoietic stem cell production from human fetus dorsal aorta and non-differentiating stem cell growth factor; for disease gene transfer vector and gene therapy.
Systemix WO 97-09520
New packaging cell lines that produce retroviral vectors of high transduction efficiencymouse leukemia virus, retrovirus packaging cell culture for use in gene therapy vector production; for gene transfer to, e.g., human hematopoietic stem cell.
Systemix WO 97-09511
Cultivation of hematopoietic stem cellsin media containing new synthetic proteoglycan(s).
University of Minnesota US 5605829-A
Stimulation of immune response to tumorcytokine-mediated gene therapy of melanoma or carcinoma using retrovirus vector expressing granulocyte-macrophage colony stimulating factor.
Whitehead-Inst. Biomed. Res. WO 97-09495
| ||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |